Insider Cluster (3 insiders) ·Filed May 22, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $540K total
Actionable Insight • Neutral

No actionable signal. The cluster consists entirely of derivative-exercise-and-sell transactions by two insiders — a standard pattern for tax withholding and cashless exercise. With CMO Joana Goncalves also selling a smaller lot, there is no evidence of coordinated bearish conviction. Historical calibration shows ORKA insider cluster reports have been unreliable, with the model's T+20 average alpha at -0.96% in this segment. Ignore this cluster.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ORKA ▲ +85.73% at T+60d
NEUTRAL call ✓ call won +85.73% · α vs SPY +83.00% · entry $59.06 → $109.69
Entry anchored
May 22, 2026
via day open
T+1d
-1.81%
call -1.81% · α -1.82%
$57.99
settled 4mo ago
T+5d
-6.48%
call -6.48% · α -7.70%
$55.23
settled 4mo ago
T+20d
+41.58%
call +41.58% · α +43.52%
$83.62
settled 3mo ago
T+60d
+85.73%
call +85.73% · α +83.00%
$109.69
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Director Carl Dambkowski and SVP Arjun Agarwal executed derivative exercises and open-market sales, with total open-market sales of ~$2.78M on the cluster window. The sales are modest relative to ORKA's $3.5B market cap (~0.08%) and are tied to derivative exercise/cashless exercise-and-sell patterns — a routine liquidity mechanism rather than informed selling.

Key Financial Metrics

Direction
selling
Total Value
$2.8M
Insiders
3

Key Facts

  • Director Carl Dambkowski sold 38,318 shares on 2026-05-21 at ~$58.43 for ~$2.24M, combined with derivative exercises (38,689 shares at $6.84 and 11,904 shares at $0).
  • SVP Arjun Agarwal sold 4,190 shares on 2026-05-18 at ~$58.34 for ~$244K, combined with derivative exercises (2,000 shares at $12.50 and 2,000 shares at $0).
  • Total open-market sales: ~$2.78M, representing ~0.08% of ORKA's $3.5B market cap.
  • CMO Joana Goncalves sold 4.8K shares at ~$61.56 for ~$295K in the 7d window — an additional partial cluster participant.
  • All sales in the cluster are derivative-related, not outright open-market portfolio liquidation.

Financial Impact

Total insider sale value of ~$2.78M is trivial relative to $3.5B market cap (~0.08%) — noise floor.

insider holdings reductiondilution from derivative exercises

Risk Factors

  • If the company is in a pre-approval or data-readout window, any insider sale gets outsized attention — manage headline risk.
  • Non-open-market exercises (A, M, F) do not reflect bearish conviction but are often mischaracterized by retail media.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ORKA-1779483291571
26 reports for ORKA
Performance horizon
100% Hit rate 11 of 11 directional calls best @ T+60▲ +80.05%Jun 1, 2026
Filters
Rows
Reports for ORKA — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 3/10
$93.55 $89.93▼ −3.87%▼ −6.44%$84.38 (−9.80%)
Sep 1, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$91.63 $91.65▼ −0.02%▼ −0.98%$84.38 (+7.91%)
Aug 28, 2026
5w ago
EFFECT
BEARISH ★ 6/10
$91.15 $92.51▼ −1.50%▼ −1.39%$84.38 (+7.42%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.08 $101.82▼ −9.96%▼ −9.76%$84.38 (−25.38%)
Aug 10, 2026
7w ago
Press Release
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 10, 2026
7w ago
8-K
BULLISH ★ 6/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Jul 15, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$83.04 $91.95▲ +10.73%▲ +12.40%$84.38 (+1.61%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 5/10
$85.21 $88.27▲ +3.59%▲ +2.66%$84.38 (−0.97%)
Jun 22, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$83.40 $92.49▲ +10.90%▲ +9.89%$84.38 (+1.18%)
Showing 10 of 26

US Market Status

Market Open — Closes in 3h 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 22, 2026